Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Galectin Therapeutics Inc. - Common Stock (NQ:GALT)

5.200 +0.600 (+13.04%)
Streaming Delayed Price Updated: 2:16 PM EDT, Jul 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,687,419
Open 4.700
Bid (Size) 5.180 (100)
Ask (Size) 5.220 (400)
Prev. Close 4.600
Today's Range 4.660 - 5.550
52wk Range 2.025 - 7.130
Shares Outstanding 59,395,805
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT
From Pomerantz LLP
Via GlobeNewswire
News headline image
The Great Rebalancing: Small-Cap Stocks Surge as Market Rotation Deepens in Early 2026
As of January 16, 2026, the financial markets are witnessing a profound "regime shift" that has caught many institutional investors by surprise. After more than a decade of large-cap technology... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy

Performance

YTD
+28.4%
+28.4%
1 Month
+98.5%
+98.5%
3 Month
+121.3%
+121.3%
6 Month
+64.6%
+64.6%
1 Year
+82.5%
+82.5%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT
From Pomerantz LLP
Via GlobeNewswire
Why Did GALT Shares Plummet Over 30% Today? ↗
Via Stocktwits
News headline image
GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of - GALT
From Pomerantz LLP
Via GlobeNewswire
News headline image
GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with The Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Galectin Beats Q2 Loss Estimates ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
Via FinancialNewsMedia
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Dow Surges Over 600 Points, Gold Jumps 1.5% ↗
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Galectin Therapeutics Inc. - Common Stock publicly traded?
Yes, Galectin Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Galectin Therapeutics Inc. - Common Stock trade on?
Galectin Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Galectin Therapeutics Inc. - Common Stock?
The ticker symbol for Galectin Therapeutics Inc. - Common Stock is GALT on the Nasdaq Stock Market
What is the current price of Galectin Therapeutics Inc. - Common Stock?
The current price of Galectin Therapeutics Inc. - Common Stock is 5.200
When was Galectin Therapeutics Inc. - Common Stock last traded?
The last trade of Galectin Therapeutics Inc. - Common Stock was at 07/14/26 02:16 PM ET
What is the market capitalization of Galectin Therapeutics Inc. - Common Stock?
The market capitalization of Galectin Therapeutics Inc. - Common Stock is 308.86M
How many shares of Galectin Therapeutics Inc. - Common Stock are outstanding?
Galectin Therapeutics Inc. - Common Stock has 309M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.